The Cardiovascular Genescreen can distinguish between high-risk individuals who require long-term medical treatment and those at increased risk of CVD and related disorders due to less severe gene-environment interactions. By identifying multiple risk factors that may interact with each other to increase the risk, a cumulative effect leading to disease development or progression may be prevented through targeted intervention. Although the CVD test is performed only once in a lifetime, it provides lifelong information on risk factors and determines larger than average fluctuation in risk factor levels in certain environments.
